209 related articles for article (PubMed ID: 25312588)
1. Advances in kinase targeting: current clinical use and clinical trials.
Rask-Andersen M; Zhang J; Fabbro D; Schiöth HB
Trends Pharmacol Sci; 2014 Nov; 35(11):604-20. PubMed ID: 25312588
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase inhibitors: insights into drug design from structure.
Noble ME; Endicott JA; Johnson LN
Science; 2004 Mar; 303(5665):1800-5. PubMed ID: 15031492
[TBL] [Abstract][Full Text] [Related]
3. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
4. Role of tyrosine kinase inhibitors in cancer therapy.
Arora A; Scholar EM
J Pharmacol Exp Ther; 2005 Dec; 315(3):971-9. PubMed ID: 16002463
[TBL] [Abstract][Full Text] [Related]
5. Kinase inhibitors for CNS diseases: an analysis of the recent patent literature.
Amigoni F; Legnaghi E; Pevarello P
Pharm Pat Anal; 2012 May; 1(2):177-92. PubMed ID: 24236782
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer with small-molecular-weight kinase inhibitors.
Fabbro D; Cowan-Jacob SW; Möbitz H; Martiny-Baron G
Methods Mol Biol; 2012; 795():1-34. PubMed ID: 21960212
[TBL] [Abstract][Full Text] [Related]
7. Protein kinases as targets for cancer treatment.
Giamas G; Stebbing J; Vorgias CE; Knippschild U
Pharmacogenomics; 2007 Aug; 8(8):1005-16. PubMed ID: 17716234
[TBL] [Abstract][Full Text] [Related]
8. New targeted therapies for gastric cancer.
Asaoka Y; Ikenoue T; Koike K
Expert Opin Investig Drugs; 2011 May; 20(5):595-604. PubMed ID: 21406037
[TBL] [Abstract][Full Text] [Related]
9. The evolving landscape of protein kinases in breast cancer: clinical implications.
Ocaña A; Amir E; Seruga B; Martin M; Pandiella A
Cancer Treat Rev; 2013 Feb; 39(1):68-76. PubMed ID: 22703833
[TBL] [Abstract][Full Text] [Related]
10. [Future aspects of the treatment of pulmonary arterial hypertension].
Ghofrani HA; Rosenkranz S; Grimminger F
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S338-40. PubMed ID: 17139602
[TBL] [Abstract][Full Text] [Related]
11. Disease mechanisms and emerging therapies: protein kinases and their inhibitors in myocardial disease.
Anderson ME; Higgins LS; Schulman H
Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):437-45. PubMed ID: 16874356
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of the anaplastic lymphoma kinase.
Mologni L
Expert Opin Investig Drugs; 2012 Jul; 21(7):985-94. PubMed ID: 22612599
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies.
Bagrodia S; Smeal T; Abraham RT
Pigment Cell Melanoma Res; 2012 Nov; 25(6):819-31. PubMed ID: 22883054
[TBL] [Abstract][Full Text] [Related]
14. The role of targeting mammalian target of rapamycin in lung cancer.
Pal SK; Figlin RA; Reckamp KL
Clin Lung Cancer; 2008 Nov; 9(6):340-5. PubMed ID: 19073516
[TBL] [Abstract][Full Text] [Related]
15. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
16. Is there a future for Aurora kinase inhibitors for anticancer therapy?
Carpinelli P; Moll J
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
[TBL] [Abstract][Full Text] [Related]
17. New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.
Albert S; Serova M; Dreyer C; Sablin MP; Faivre S; Raymond E
Expert Opin Investig Drugs; 2010 Aug; 19(8):919-30. PubMed ID: 20569080
[TBL] [Abstract][Full Text] [Related]
18. Kinase inhibitors: a new approach to rheumatoid arthritis treatment.
Cohen S; Fleischmann R
Curr Opin Rheumatol; 2010 May; 22(3):330-5. PubMed ID: 20164774
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors in cancer therapy.
Madhusudan S; Ganesan TS
Clin Biochem; 2004 Jul; 37(7):618-35. PubMed ID: 15234243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
